Logo image of CODX

CO-DIAGNOSTICS INC (CODX) Stock Price, Quote, News and Overview

NASDAQ:CODX - Nasdaq - US1897631057 - Common Stock - Currency: USD

0.61  -0.09 (-13.48%)

After market: 0.6313 +0.02 (+3.49%)

CODX Quote, Performance and Key Statistics

CO-DIAGNOSTICS INC

NASDAQ:CODX (2/24/2025, 6:06:18 PM)

After market: 0.6313 +0.02 (+3.49%)

0.61

-0.09 (-13.48%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High2.23
52 Week Low0.6
Market Cap19.48M
Shares31.93M
Float29.79M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-12 2025-03-12/amc
IPO07-12 2017-07-12


CODX short term performance overview.The bars show the price performance of CODX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

CODX long term performance overview.The bars show the price performance of CODX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CODX is 0.61 USD. In the past month the price decreased by -24.03%. In the past year, price decreased by -47.34%.

CO-DIAGNOSTICS INC / CODX Daily stock chart

CODX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.9 234.07B
ISRG INTUITIVE SURGICAL INC 80.63 210.79B
BSX BOSTON SCIENTIFIC CORP 41.59 153.85B
SYK STRYKER CORP 31.82 147.88B
MDT MEDTRONIC PLC 16.89 115.62B
BDX BECTON DICKINSON AND CO 16.56 66.13B
EW EDWARDS LIFESCIENCES CORP 27.77 42.91B
GEHC GE HEALTHCARE TECHNOLOGY 20.17 41.38B
IDXX IDEXX LABORATORIES INC 41.21 37.96B
DXCM DEXCOM INC 55 35.45B
RMD RESMED INC 25.98 33.73B
PHG KONINKLIJKE PHILIPS NVR- NY 17.79 24.42B

About CODX

Company Profile

CODX logo image Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 155 full-time employees. The company went IPO on 2017-07-12. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The firm also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. The company is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Company Info

CO-DIAGNOSTICS INC

4049 S Highland Dr

Salt Lake City UTAH 84109 US

CEO: Dwight Egan

Employees: 155

Company Website: http://codiagnostics.com/

Investor Relations: https://ir.codiagnostics.com/

Phone: 18012789769

CO-DIAGNOSTICS INC / CODX FAQ

What is the stock price of CO-DIAGNOSTICS INC today?

The current stock price of CODX is 0.61 USD. The price decreased by -13.48% in the last trading session.


What is the ticker symbol for CO-DIAGNOSTICS INC stock?

The exchange symbol of CO-DIAGNOSTICS INC is CODX and it is listed on the Nasdaq exchange.


On which exchange is CODX stock listed?

CODX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for CO-DIAGNOSTICS INC stock?

6 analysts have analysed CODX and the average price target is 1.53 USD. This implies a price increase of 150.82% is expected in the next year compared to the current price of 0.61. Check the CO-DIAGNOSTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CO-DIAGNOSTICS INC worth?

CO-DIAGNOSTICS INC (CODX) has a market capitalization of 19.48M USD. This makes CODX a Nano Cap stock.


How many employees does CO-DIAGNOSTICS INC have?

CO-DIAGNOSTICS INC (CODX) currently has 155 employees.


What are the support and resistance levels for CO-DIAGNOSTICS INC (CODX) stock?

CO-DIAGNOSTICS INC (CODX) has a resistance level at 0.74. Check the full technical report for a detailed analysis of CODX support and resistance levels.


Is CO-DIAGNOSTICS INC (CODX) expected to grow?

The Revenue of CO-DIAGNOSTICS INC (CODX) is expected to decline by -39.83% in the next year. Check the estimates tab for more information on the CODX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CO-DIAGNOSTICS INC (CODX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CO-DIAGNOSTICS INC (CODX) stock pay dividends?

CODX does not pay a dividend.


When does CO-DIAGNOSTICS INC (CODX) report earnings?

CO-DIAGNOSTICS INC (CODX) will report earnings on 2025-03-12, after the market close.


What is the Price/Earnings (PE) ratio of CO-DIAGNOSTICS INC (CODX)?

CO-DIAGNOSTICS INC (CODX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.27).


What is the Short Interest ratio of CO-DIAGNOSTICS INC (CODX) stock?

The outstanding short interest for CO-DIAGNOSTICS INC (CODX) is 0.84% of its float. Check the ownership tab for more information on the CODX short interest.


CODX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CODX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CODX. While CODX has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CODX Financial Highlights

Over the last trailing twelve months CODX reported a non-GAAP Earnings per Share(EPS) of -1.27. The EPS increased by 8.63% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -57.04%
ROE -64.73%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-60%
Sales Q2Q%-73.91%
EPS 1Y (TTM)8.63%
Revenue 1Y (TTM)57.1%

CODX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 43% to CODX. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of -2.84% and a revenue growth -39.83% for CODX


Ownership
Inst Owners18.02%
Ins Owners6.7%
Short Float %0.84%
Short Ratio1.27
Analysts
Analysts43.33
Price Target1.53 (150.82%)
EPS Next Y-2.84%
Revenue Next Year-39.83%